证券之星消息，截至2025年12月8日收盘，新华医疗(600587)报收于15.05元，下跌0.66%，换手率 1.07%，成交量6.48万手，成交额9773.75万元。 12月8日的资金流向数据方面，主力资金净流入843.47万元，占总成交额8.63%，游资资金净流出72.5万 元，占总成交额0.74%，散户资金净流出770.96万元，占总成交额7.89%。 近5日资金流向一览见下表： | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 散户净流入 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-12-08 | 15.05 | -0.66% | 843.47万 | 8.63% | -72.50万 | -0.74% | -770.96万 | -7.89% | | 2025-12-05 | 15.15 | 0.73% | ● 131.51万 | 1.78% | 589.13万 | 7.99% | -720.64万 | -9.78% | | 2025-12-04 | 15.04 ...

Core Viewpoint - Xinhua Medical (600587) has shown a slight increase in stock price, but the company is facing declining revenues and profits, indicating potential challenges ahead in the medical device industry [1][3]. Financial Performance - As of October 20, 2025, Xinhua Medical's stock closed at 16.44 yuan, up 1.48% with a trading volume of 79,700 hands and a turnover of 131 million yuan [1]. - The company reported a total revenue of 4.79 billion yuan for the first half of 2025, a year-on-year decrease of 7.64%, and a net profit of 386 million yuan, down 20.35% year-on-year [3]. - The second quarter of 2025 saw a single-quarter revenue of 2.48 billion yuan, a decline of 6.59% year-on-year, and a net profit of 225 million yuan, down 17.55% year-on-year [3]. Market Position - Xinhua Medical's total market capitalization is 9.974 billion yuan, with a net asset value of 8.188 billion yuan, ranking 38th in the medical device industry [3]. - The company's price-to-earnings ratio (P/E) is 12.93, significantly lower than the industry average of 65.67, indicating a potentially undervalued stock [3]. - The gross margin stands at 25.21%, which is considerably lower than the industry average of 51.83%, suggesting operational inefficiencies [3]. Investment Sentiment - In the last 90 days, two institutions have rated Xinhua Medical with a "buy" recommendation, and the average target price set by these institutions is 20.0 yuan [4].